Comparison of Conventional Dose Versus Superdose Platelet-Rich Plasma for Knee Osteoarthritis: A Prospective, Triple-Blind, Randomized Clinical Trial
In brief
In this triple-blind randomised trial, people with early knee osteoarthritis were given a single platelet-rich plasma (PRP) injection at either a conventional dose or a larger “superdose” carrying more platelets. Both groups improved in pain and function over several months, and the authors report that the larger dose gave noticeably greater improvement.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Comparison of Conventional Dose Versus Superdose Platelet-Rich Plasma for Knee Osteoarthritis: A Prospective, Triple-Blind, Randomized Clinical Trial Authors: Sandeep Patel, Shivam Gahlaut, Tarkik Thami, Devendra Kumar Chouhan, Ashish Jain, Mandeep Singh Dhillon Link: https://search.app/YDP2ygwx45DotJZV8 Year of Publication: 2024
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

